bullish
Pre-IPO MicroPort CardioFlow - A Better Candidate of the TAVR Market in China?
382 Views16 Dec 2020 09:23
This article analyzed the market potential of TAVR in China, competition pattern of key players, financial position of MicroPort CardioFlow and also provided some thoughts on valuation.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- Pre-IPO Raily Aesthetic Medicine (2135.HK) - Here Are the Concerns24 Dec 2020
- Pre-IPO Basecare Medical - Here Are the the Strengths and Concerns23 Dec 2020
- Pre-IPO Yidu Tech Inc - The Future Performance Is Worth Looking Forward To22 Dec 2020
- Pre-IPO MicroPort CardioFlow - A Better Candidate of the TAVR Market in China?16 Dec 2020
- China Healthcare Weekly (Dec.11)14 Dec 2020
- Aier Eye Hospital(300015.CH) - The Largest Ophthalmic Chain in China with Promising Growth Potential09 Dec 2020
- Pre-IPO Jacobio Pharmaceuticals - Insights on Pipeline08 Dec 2020
x